Alzheimer's drug candidate BNC tested in healthy seniors for first time
NCT ID NCT01747213
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 28 times
Summary
This early-stage study tested a single dose of an experimental drug called BNC in 75 healthy volunteers aged 55 and older. The goal was to see if the drug is safe and how the body processes it, as a first step toward possibly treating Alzheimer's disease. Participants took either BNC or a placebo and were monitored closely for side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harbor Hospital Center
Baltimore, Maryland, United States
-
National Institute on Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.